Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Marco Del Chiaro

Concepts (574)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
161
2025
875
32.550
 Why?
Pancreatectomy
69
2025
241
16.940
 Why?
Carcinoma, Pancreatic Ductal
67
2025
269
16.510
 Why?
Pancreaticoduodenectomy
32
2025
158
6.920
 Why?
Adenocarcinoma
28
2025
889
6.370
 Why?
Neoadjuvant Therapy
28
2025
378
5.530
 Why?
Pancreas
38
2024
304
4.400
 Why?
Adenocarcinoma, Mucinous
16
2024
73
3.810
 Why?
Mesenteric Veins
7
2025
18
3.120
 Why?
Pancreatic Cyst
11
2024
51
2.750
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2025
1559
2.340
 Why?
Pancreatic Fistula
11
2023
27
2.250
 Why?
Portal Vein
11
2025
108
2.240
 Why?
Ampulla of Vater
7
2025
39
2.130
 Why?
Common Bile Duct Neoplasms
6
2025
27
2.090
 Why?
Carcinoma, Papillary
9
2021
76
2.010
 Why?
Retrospective Studies
88
2025
14532
1.870
 Why?
Pancreatic Ducts
10
2022
79
1.860
 Why?
Humans
238
2025
129527
1.850
 Why?
CA-19-9 Antigen
4
2024
22
1.770
 Why?
Aged
86
2025
22063
1.720
 Why?
Exocrine Pancreatic Insufficiency
5
2019
20
1.620
 Why?
Prognosis
30
2025
3772
1.610
 Why?
Survival Rate
22
2025
1870
1.530
 Why?
Early Detection of Cancer
6
2021
371
1.520
 Why?
Middle Aged
93
2025
31087
1.460
 Why?
Neoplasm Recurrence, Local
6
2024
956
1.440
 Why?
Gastrointestinal Neoplasms
2
2023
72
1.410
 Why?
Vascular Surgical Procedures
4
2025
295
1.350
 Why?
Mesenteric Artery, Superior
4
2020
15
1.330
 Why?
Pancreas Transplantation
24
2010
75
1.320
 Why?
Postoperative Complications
30
2025
2475
1.230
 Why?
Male
109
2025
63586
1.190
 Why?
Aged, 80 and over
43
2025
7052
1.190
 Why?
Pancreatitis, Chronic
6
2020
51
1.160
 Why?
Treatment Outcome
40
2025
10232
1.090
 Why?
Female
105
2025
68650
1.070
 Why?
Quality of Life
8
2025
2694
1.070
 Why?
Islets of Langerhans
5
2020
790
1.010
 Why?
Carcinoma, Neuroendocrine
2
2023
32
1.000
 Why?
Chemotherapy, Adjuvant
13
2025
376
0.990
 Why?
Liver Neoplasms
4
2024
635
0.990
 Why?
Endosonography
5
2021
141
0.980
 Why?
Biomarkers, Tumor
13
2024
1159
0.940
 Why?
Databases, Factual
3
2024
1261
0.930
 Why?
Nomograms
3
2022
47
0.930
 Why?
Precancerous Conditions
3
2015
160
0.920
 Why?
Follow-Up Studies
23
2024
4891
0.890
 Why?
Adult
70
2025
35505
0.890
 Why?
Hepatoblastoma
1
2024
42
0.880
 Why?
Duodenal Neoplasms
3
2023
21
0.870
 Why?
Neoplasms, Cystic, Mucinous, and Serous
3
2023
25
0.860
 Why?
Thrombelastography
2
2024
150
0.850
 Why?
Minimally Invasive Surgical Procedures
3
2020
175
0.780
 Why?
Risk Assessment
11
2025
3255
0.720
 Why?
Surgical Stapling
1
2021
14
0.720
 Why?
Absorbable Implants
1
2021
35
0.710
 Why?
Fluorouracil
10
2025
197
0.710
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2022
197
0.700
 Why?
Organ Transplantation
2
2023
228
0.690
 Why?
Neoplasm Staging
12
2024
1281
0.690
 Why?
Cystadenocarcinoma, Mucinous
2
2018
14
0.680
 Why?
Neoplasms, Second Primary
2
2019
106
0.680
 Why?
Leucovorin
7
2025
70
0.670
 Why?
Neoplasm Invasiveness
7
2020
481
0.670
 Why?
Sweden
6
2025
93
0.670
 Why?
Vascular Neoplasms
1
2020
17
0.660
 Why?
Neoplasms, Multiple Primary
3
2015
55
0.660
 Why?
Arteries
2
2019
266
0.650
 Why?
Pancreatitis
5
2022
124
0.650
 Why?
Liver Transplantation
4
2024
833
0.640
 Why?
Adenocarcinoma, Papillary
2
2017
11
0.640
 Why?
Endocrine System Diseases
1
2019
33
0.630
 Why?
Practice Guidelines as Topic
4
2024
1510
0.630
 Why?
Neuroendocrine Tumors
4
2023
99
0.610
 Why?
Cohort Studies
12
2024
5423
0.580
 Why?
Europe
8
2021
362
0.550
 Why?
Patient Compliance
1
2021
567
0.550
 Why?
Evidence-Based Medicine
5
2024
715
0.550
 Why?
Metabolomics
2
2019
652
0.540
 Why?
Patient Selection
9
2024
659
0.540
 Why?
Kidney Transplantation
17
2016
669
0.530
 Why?
Living Donors
3
2016
286
0.530
 Why?
Neoplasm Metastasis
1
2019
609
0.520
 Why?
Hepatic Artery
4
2020
58
0.520
 Why?
Celiac Artery
4
2020
10
0.520
 Why?
Watchful Waiting
1
2016
67
0.520
 Why?
Hepatitis B virus
1
2016
36
0.500
 Why?
Pancreaticojejunostomy
3
2022
8
0.500
 Why?
Prospective Studies
15
2024
7150
0.490
 Why?
Hypothermia, Induced
1
2016
76
0.480
 Why?
Disease Progression
5
2022
2628
0.460
 Why?
Organ Sparing Treatments
1
2015
32
0.460
 Why?
Survival Analysis
12
2024
1270
0.460
 Why?
Pancreatic Diseases
3
2020
71
0.460
 Why?
Adenoma
3
2025
211
0.450
 Why?
Antineoplastic Agents
6
2021
2044
0.440
 Why?
Risk Factors
16
2024
9779
0.430
 Why?
Deoxycytidine
8
2025
163
0.430
 Why?
Clinical Trials as Topic
1
2018
1001
0.430
 Why?
Carcinoma, Hepatocellular
1
2016
270
0.430
 Why?
Japan
5
2025
98
0.420
 Why?
Palliative Care
3
2019
704
0.420
 Why?
Radiotherapy, Adjuvant
2
2024
208
0.420
 Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2019
206
0.420
 Why?
Combined Modality Therapy
5
2024
1201
0.410
 Why?
Cystadenocarcinoma
1
2013
2
0.410
 Why?
Cystadenoma
1
2013
3
0.410
 Why?
Stomach Neoplasms
2
2024
97
0.400
 Why?
Robotics
1
2014
92
0.400
 Why?
Tomography, X-Ray Computed
10
2021
2503
0.400
 Why?
Autoimmune Diseases
3
2021
428
0.390
 Why?
Cystadenoma, Serous
3
2020
18
0.390
 Why?
Diabetes Mellitus
3
2019
988
0.390
 Why?
Italy
11
2013
98
0.390
 Why?
Incidence
8
2019
2643
0.380
 Why?
Diagnosis, Differential
8
2022
1422
0.370
 Why?
Peritoneal Neoplasms
2
2024
86
0.370
 Why?
Dilatation, Pathologic
3
2020
60
0.370
 Why?
Propensity Score
3
2025
266
0.360
 Why?
Gastroenterology
2
2023
177
0.350
 Why?
Risk
5
2022
857
0.350
 Why?
Gamma Rays
2
2021
54
0.340
 Why?
Magnetic Resonance Imaging
8
2021
3392
0.340
 Why?
Neoplastic Syndromes, Hereditary
1
2010
37
0.330
 Why?
Chemoradiotherapy
2
2022
208
0.330
 Why?
Portal System
6
2020
13
0.330
 Why?
Tissue Donors
14
2005
391
0.330
 Why?
Microbiota
3
2025
734
0.330
 Why?
Adolescent
15
2022
20409
0.320
 Why?
Neoplasm Grading
4
2020
283
0.320
 Why?
Decision Making
1
2016
860
0.310
 Why?
Kidney
2
2016
1382
0.310
 Why?
Lymphatic Metastasis
3
2024
319
0.310
 Why?
Age Factors
6
2022
3150
0.300
 Why?
Population Surveillance
2
2019
440
0.300
 Why?
Young Adult
11
2022
12438
0.300
 Why?
Benchmarking
2
2020
175
0.300
 Why?
Mass Screening
2
2019
1186
0.300
 Why?
Tumor Burden
2
2022
287
0.290
 Why?
Software
2
2017
608
0.290
 Why?
Predictive Value of Tests
5
2024
1950
0.280
 Why?
Laparoscopy
3
2021
446
0.280
 Why?
Graft Survival
12
2005
514
0.280
 Why?
Genetic Predisposition to Disease
6
2019
2271
0.270
 Why?
Islets of Langerhans Transplantation
3
2020
63
0.270
 Why?
Internationality
4
2020
150
0.270
 Why?
Disease-Free Survival
5
2023
647
0.260
 Why?
Cytoreduction Surgical Procedures
2
2024
59
0.260
 Why?
Family Health
1
2007
198
0.260
 Why?
Drainage
10
2022
164
0.260
 Why?
Pedigree
3
2014
482
0.260
 Why?
Multidetector Computed Tomography
2
2016
33
0.250
 Why?
Length of Stay
5
2021
1132
0.250
 Why?
Observer Variation
2
2024
314
0.250
 Why?
Cholangiocarcinoma
2
2024
77
0.240
 Why?
Cyst Fluid
2
2022
25
0.240
 Why?
Immunohistochemistry
5
2019
1684
0.240
 Why?
Lymphocytes, Tumor-Infiltrating
2
2018
204
0.240
 Why?
Proportional Hazards Models
4
2023
1196
0.230
 Why?
Mucosal-Associated Invariant T Cells
1
2025
27
0.230
 Why?
Pylorus
1
2024
17
0.230
 Why?
Chemoradiotherapy, Adjuvant
3
2019
41
0.230
 Why?
Gallbladder Neoplasms
1
2024
21
0.230
 Why?
Perioperative Care
2
2024
165
0.230
 Why?
Spheroids, Cellular
1
2025
76
0.220
 Why?
Time Factors
10
2021
6530
0.220
 Why?
Prevalence
3
2023
2561
0.210
 Why?
Lymph Node Excision
1
2024
164
0.210
 Why?
Incidental Findings
2
2021
80
0.210
 Why?
Bile Duct Neoplasms
1
2024
99
0.210
 Why?
Metastasectomy
1
2023
19
0.210
 Why?
Hyperemia
1
2023
48
0.210
 Why?
Hospital Mortality
4
2020
851
0.210
 Why?
Reoperation
7
2018
542
0.200
 Why?
Pilot Projects
5
2023
1594
0.200
 Why?
Surgical Oncology
1
2022
22
0.200
 Why?
Hyperamylasemia
1
2022
3
0.200
 Why?
STAT3 Transcription Factor
2
2022
194
0.190
 Why?
Pancreatitis, Acute Necrotizing
1
2022
12
0.190
 Why?
Forecasting
1
2023
360
0.190
 Why?
Colonic Neoplasms
1
2024
241
0.190
 Why?
Carcinoma, Acinar Cell
1
2021
4
0.190
 Why?
Plastics
1
2022
47
0.190
 Why?
Multicenter Studies as Topic
1
2023
287
0.190
 Why?
Angiotensin Receptor Antagonists
1
2022
89
0.180
 Why?
Biliary Tract Surgical Procedures
1
2021
25
0.180
 Why?
Pathology, Clinical
1
2021
36
0.180
 Why?
Datasets as Topic
1
2021
109
0.180
 Why?
Cysts
1
2022
108
0.180
 Why?
Bacteria
2
2025
812
0.180
 Why?
ADAM10 Protein
1
2021
30
0.180
 Why?
Surgical Mesh
1
2021
46
0.180
 Why?
Fusobacterium nucleatum
1
2020
3
0.170
 Why?
Fusobacterium Infections
1
2020
7
0.170
 Why?
Netherlands
3
2025
77
0.170
 Why?
Digestive System Surgical Procedures
1
2021
98
0.170
 Why?
Body Composition
1
2024
649
0.170
 Why?
Amyloid Precursor Protein Secretases
1
2021
78
0.170
 Why?
Child, Preschool
4
2024
10499
0.170
 Why?
Microdissection
2
2011
15
0.170
 Why?
Oligonucleotides, Antisense
1
2020
111
0.170
 Why?
Antimetabolites, Antineoplastic
2
2010
91
0.170
 Why?
Blood
1
2020
105
0.170
 Why?
Comorbidity
2
2022
1548
0.160
 Why?
Radiation Injuries
1
2021
135
0.160
 Why?
Myeloid-Derived Suppressor Cells
1
2020
64
0.160
 Why?
Antibodies, Bacterial
1
2020
139
0.160
 Why?
Conservative Treatment
1
2020
32
0.160
 Why?
Cyclosporine
4
2005
263
0.160
 Why?
Cystadenocarcinoma, Serous
1
2020
68
0.160
 Why?
Dilatation
1
2019
62
0.160
 Why?
Lasers
2
2011
133
0.160
 Why?
Elective Surgical Procedures
1
2020
165
0.150
 Why?
Biliary Tract Diseases
1
2019
36
0.150
 Why?
Epithelial-Mesenchymal Transition
1
2021
201
0.150
 Why?
Bacterial Infections
1
2021
234
0.150
 Why?
Laparotomy
2
2016
104
0.150
 Why?
Saliva
1
2020
212
0.150
 Why?
Sensitivity and Specificity
2
2021
1842
0.150
 Why?
Bile Ducts
1
2019
68
0.150
 Why?
Mouth
1
2019
84
0.150
 Why?
Referral and Consultation
1
2024
732
0.150
 Why?
Organ Culture Techniques
1
2019
155
0.150
 Why?
Patient Care Team
3
2020
600
0.150
 Why?
Immunosuppressive Agents
6
2005
858
0.150
 Why?
Gene Expression Regulation, Neoplastic
4
2019
1327
0.150
 Why?
Insulin
8
2013
2313
0.150
 Why?
Nutritional Support
1
2018
32
0.150
 Why?
DNA Damage
1
2021
383
0.150
 Why?
Fibrosis
1
2021
526
0.150
 Why?
Societies, Medical
2
2020
757
0.150
 Why?
Iopamidol
2
2016
16
0.150
 Why?
Recombinant Fusion Proteins
4
2005
650
0.140
 Why?
Patient Acceptance of Health Care
1
2024
761
0.140
 Why?
Jejunum
2
2016
30
0.140
 Why?
Carcinoma
1
2019
213
0.140
 Why?
Radiosurgery
1
2020
321
0.140
 Why?
DNA, Bacterial
1
2019
323
0.140
 Why?
Kaplan-Meier Estimate
2
2016
850
0.140
 Why?
Logistic Models
2
2020
1983
0.140
 Why?
Malnutrition
1
2018
79
0.140
 Why?
Cross-Sectional Studies
3
2024
5078
0.140
 Why?
Biliary Tract Neoplasms
1
2016
25
0.130
 Why?
Hepatic Duct, Common
1
2016
6
0.130
 Why?
Jaundice, Obstructive
1
2016
2
0.130
 Why?
Hyperglycemia
1
2020
325
0.130
 Why?
Epitopes
1
2018
473
0.130
 Why?
Cholangiopancreatography, Magnetic Resonance
1
2016
16
0.130
 Why?
Triiodobenzoic Acids
1
2016
9
0.130
 Why?
Organ Preservation Solutions
3
2005
45
0.130
 Why?
Cholangitis, Sclerosing
1
2016
71
0.130
 Why?
Radiographic Image Enhancement
1
2016
54
0.120
 Why?
Sex Factors
1
2022
1966
0.120
 Why?
Cannabis
1
2023
461
0.120
 Why?
Embolization, Therapeutic
1
2018
207
0.120
 Why?
Machine Learning
1
2020
441
0.120
 Why?
Printing, Three-Dimensional
1
2016
88
0.120
 Why?
Bacteriocins
1
2015
2
0.120
 Why?
Pneumonia, Viral
1
2020
342
0.120
 Why?
Hepatitis B
1
2016
66
0.120
 Why?
Genes, BRCA2
1
2015
22
0.120
 Why?
Recovery of Function
1
2019
644
0.120
 Why?
Coronavirus Infections
1
2020
336
0.120
 Why?
Genes, BRCA1
1
2015
30
0.120
 Why?
Organ Preservation
3
2004
94
0.120
 Why?
Interferon-gamma
1
2018
773
0.120
 Why?
Surveys and Questionnaires
4
2022
5429
0.120
 Why?
Diabetes Mellitus, Type 1
10
2010
3622
0.120
 Why?
Papilloma, Intraductal
1
2014
3
0.120
 Why?
Heredity
1
2014
12
0.120
 Why?
Genomics
2
2017
715
0.110
 Why?
Membrane Proteins
1
2021
1118
0.110
 Why?
Albumins
2
2025
104
0.110
 Why?
Germany
2
2024
100
0.110
 Why?
Amylases
1
2013
16
0.110
 Why?
Risk Adjustment
1
2014
78
0.110
 Why?
Neoplasm, Residual
1
2014
121
0.110
 Why?
High-Throughput Nucleotide Sequencing
1
2017
486
0.110
 Why?
Apoptosis
6
2021
2488
0.110
 Why?
Reproducibility of Results
6
2019
3081
0.110
 Why?
Antibodies, Monoclonal
4
2005
1366
0.110
 Why?
Tissue and Organ Harvesting
5
2005
70
0.110
 Why?
Paclitaxel
2
2025
217
0.110
 Why?
Perception
1
2016
346
0.110
 Why?
Breast Neoplasms
2
2024
2101
0.110
 Why?
Severity of Illness Index
3
2019
2734
0.110
 Why?
Precision Medicine
1
2017
385
0.110
 Why?
Virus Diseases
1
2016
210
0.110
 Why?
Abdomen
2
2004
119
0.110
 Why?
North America
2
2024
294
0.110
 Why?
MicroRNAs
2
2010
677
0.110
 Why?
Cell Proliferation
5
2021
2367
0.100
 Why?
Tacrolimus
2
2005
193
0.100
 Why?
Syndrome
1
2014
338
0.100
 Why?
Cystadenoma, Mucinous
1
2013
13
0.100
 Why?
Diagnostic Imaging
1
2015
326
0.100
 Why?
Imaging, Three-Dimensional
1
2016
530
0.100
 Why?
Cadaver
8
2005
308
0.100
 Why?
Diagnostic Errors
1
2014
162
0.100
 Why?
Immunotherapy, Adoptive
1
2016
300
0.100
 Why?
ROC Curve
3
2024
503
0.100
 Why?
Neoplasms
2
2022
2450
0.100
 Why?
Insulin-Secreting Cells
2
2007
367
0.100
 Why?
Endoscopy
1
2014
290
0.100
 Why?
Catheter Ablation
1
2015
336
0.090
 Why?
Practice Patterns, Physicians'
1
2020
1257
0.090
 Why?
Preoperative Care
1
2014
337
0.090
 Why?
Receptors, Antigen, T-Cell
1
2016
707
0.090
 Why?
C-Reactive Protein
1
2013
400
0.090
 Why?
Loss of Heterozygosity
1
2011
45
0.090
 Why?
Carcinoma in Situ
1
2011
44
0.090
 Why?
Biomarkers
1
2022
3968
0.090
 Why?
Graft Rejection
5
2005
598
0.090
 Why?
Kruppel-Like Transcription Factors
1
2011
65
0.090
 Why?
United States
3
2024
13865
0.090
 Why?
Lung Neoplasms
1
2023
2342
0.080
 Why?
Raffinose
3
2005
23
0.080
 Why?
Tissue and Organ Procurement
2
2004
290
0.080
 Why?
Disaccharides
3
2005
18
0.080
 Why?
Glucose
3
2020
996
0.080
 Why?
Mannitol
3
2005
38
0.080
 Why?
Allopurinol
3
2005
62
0.080
 Why?
Histidine
3
2005
60
0.080
 Why?
Glutamates
3
2005
57
0.080
 Why?
Electrolytes
3
2005
58
0.080
 Why?
CD8-Positive T-Lymphocytes
1
2016
855
0.080
 Why?
Peptides
1
2015
925
0.080
 Why?
Quality of Health Care
1
2014
607
0.080
 Why?
Lymph Nodes
2
2024
471
0.080
 Why?
Duodenum
1
2010
74
0.080
 Why?
Cell Line, Tumor
4
2025
3181
0.080
 Why?
Tumor Cells, Cultured
2
2021
931
0.080
 Why?
Intra-Abdominal Fat
1
2009
88
0.080
 Why?
Down-Regulation
1
2011
631
0.070
 Why?
Adenosine
3
2005
225
0.070
 Why?
T-Lymphocytes, Regulatory
2
2022
372
0.070
 Why?
Glutathione
3
2005
349
0.070
 Why?
Magnetic Resonance Angiography
1
2010
234
0.070
 Why?
Enzyme Replacement Therapy
2
2018
13
0.070
 Why?
Germ-Line Mutation
2
2019
140
0.070
 Why?
Morbidity
2
2019
300
0.070
 Why?
Diabetic Retinopathy
2
2006
179
0.070
 Why?
ErbB Receptors
1
2010
605
0.070
 Why?
Gliclazide
1
2007
2
0.070
 Why?
Clinical Decision-Making
2
2020
304
0.070
 Why?
Cytotoxicity, Immunologic
2
2018
220
0.070
 Why?
Hepatectomy
2
2024
212
0.060
 Why?
Arterial Occlusive Diseases
1
2007
80
0.060
 Why?
Consensus
2
2020
622
0.060
 Why?
Equilibrative Nucleoside Transporter 1
1
2006
17
0.060
 Why?
Child
4
2024
20932
0.060
 Why?
Extracorporeal Circulation
1
2006
13
0.060
 Why?
Blood Loss, Surgical
1
2007
96
0.060
 Why?
C-Peptide
1
2007
155
0.060
 Why?
Hepatic Veins
1
2006
31
0.060
 Why?
Tumor Microenvironment
2
2020
627
0.060
 Why?
Lacerations
1
2006
29
0.060
 Why?
Vena Cava, Inferior
1
2006
68
0.060
 Why?
Alcohol Drinking
2
2013
764
0.060
 Why?
Drug Resistance, Neoplasm
1
2010
751
0.060
 Why?
Neovascularization, Pathologic
1
2007
292
0.060
 Why?
Transplantation, Autologous
1
2006
213
0.060
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
232
0.060
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
26
0.060
 Why?
Smoking
2
2013
1501
0.060
 Why?
Abdominal Injuries
1
2006
118
0.060
 Why?
Jehovah's Witnesses
1
2004
3
0.060
 Why?
Bezoars
1
2004
4
0.060
 Why?
Contrast Media
3
2016
393
0.060
 Why?
RNA, Messenger
5
2011
2697
0.050
 Why?
Anthropometry
1
2024
203
0.050
 Why?
Biopsy
3
2019
1087
0.050
 Why?
Intestinal Obstruction
1
2004
49
0.050
 Why?
Splenectomy
1
2024
58
0.050
 Why?
Chemotaxis
1
2004
130
0.050
 Why?
Consensus Development Conferences as Topic
1
2023
26
0.050
 Why?
Cystectomy
1
2003
37
0.050
 Why?
Antioxidants
1
2007
557
0.050
 Why?
Intestine, Small
1
2004
151
0.050
 Why?
Intraoperative Complications
1
2004
129
0.050
 Why?
Postoperative Period
2
2019
329
0.050
 Why?
Ileum
1
2003
116
0.050
 Why?
Wounds, Nonpenetrating
1
2006
273
0.050
 Why?
Delphi Technique
1
2024
227
0.050
 Why?
Gastrectomy
1
2023
102
0.050
 Why?
Propylamines
1
2022
11
0.050
 Why?
Genetic Testing
1
2005
422
0.050
 Why?
Carbohydrates
1
2022
64
0.050
 Why?
Stents
2
2022
504
0.050
 Why?
Azathioprine
1
2001
50
0.050
 Why?
Urinary Bladder
1
2003
176
0.050
 Why?
Creatinine
4
2004
489
0.050
 Why?
Vascular Diseases
1
2004
240
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
952
0.040
 Why?
Necrosis
1
2022
234
0.040
 Why?
Mycophenolic Acid
1
2001
110
0.040
 Why?
Retroperitoneal Space
3
2005
16
0.040
 Why?
Hernia, Inguinal
1
2001
34
0.040
 Why?
Steroids
1
2001
158
0.040
 Why?
Urinary Bladder Neoplasms
1
2003
225
0.040
 Why?
Ephrin-B2
1
2021
50
0.040
 Why?
Endometriosis
1
2001
46
0.040
 Why?
Endoscopy, Gastrointestinal
1
2023
218
0.040
 Why?
Hyperplasia
1
2021
175
0.040
 Why?
Case-Control Studies
2
2022
3383
0.040
 Why?
Microbial Viability
1
2021
83
0.040
 Why?
Medical Oncology
1
2022
267
0.040
 Why?
Adipose Tissue
1
2024
594
0.040
 Why?
Mice, Inbred C57BL
2
2021
5468
0.040
 Why?
Diagnosis, Computer-Assisted
1
2020
86
0.040
 Why?
Mice
3
2022
16973
0.040
 Why?
Capecitabine
1
2019
45
0.040
 Why?
Hematopoietic Stem Cell Transplantation
1
2005
577
0.040
 Why?
Secretin
2
2010
4
0.040
 Why?
Florida
1
2020
93
0.040
 Why?
Margins of Excision
1
2019
38
0.040
 Why?
Republic of Korea
1
2019
29
0.040
 Why?
Matched-Pair Analysis
1
2019
39
0.040
 Why?
Asia
1
2019
58
0.040
 Why?
Treatment Failure
3
2005
339
0.040
 Why?
International Cooperation
1
2020
177
0.040
 Why?
Cell Death
1
2021
352
0.040
 Why?
Hyperthermia, Induced
1
2020
108
0.040
 Why?
Acute Disease
1
2022
975
0.040
 Why?
Area Under Curve
1
2019
306
0.040
 Why?
Cells, Cultured
3
2016
4087
0.040
 Why?
Aquaporin 1
1
2018
3
0.040
 Why?
Radiotherapy
1
2019
185
0.040
 Why?
Mice, Nude
1
2020
677
0.040
 Why?
Stromal Cells
1
2019
106
0.040
 Why?
Pancreatic Elastase
1
2018
60
0.040
 Why?
Cause of Death
3
2005
395
0.040
 Why?
Congresses as Topic
1
2020
215
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
804
0.040
 Why?
Anastomosis, Roux-en-Y
2
2010
27
0.040
 Why?
Hospitals, High-Volume
1
2018
39
0.040
 Why?
Multivariate Analysis
2
2013
1491
0.040
 Why?
Preoperative Period
1
2018
116
0.040
 Why?
Anastomotic Leak
1
2017
39
0.030
 Why?
Betacoronavirus
1
2020
252
0.030
 Why?
Tumor Suppressor Protein p53
2
2017
502
0.030
 Why?
Patient Safety
1
2020
287
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2010
754
0.030
 Why?
Robotic Surgical Procedures
1
2019
113
0.030
 Why?
Diabetic Nephropathies
3
2005
284
0.030
 Why?
Intestinal Neoplasms
1
2016
28
0.030
 Why?
Cell Movement
1
2021
942
0.030
 Why?
Drug Therapy, Combination
3
2004
1037
0.030
 Why?
Principal Component Analysis
1
2016
190
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2017
259
0.030
 Why?
Transplantation, Homologous
2
2010
402
0.030
 Why?
Mass Spectrometry
1
2019
717
0.030
 Why?
Nutritional Status
1
2018
328
0.030
 Why?
Anastomosis, Surgical
1
2016
150
0.030
 Why?
Vitamins
1
2017
173
0.030
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
98
0.030
 Why?
Research Design
1
2021
1043
0.030
 Why?
Feces
1
2018
442
0.030
 Why?
Cell Line
1
2021
2774
0.030
 Why?
Animals
3
2022
35334
0.030
 Why?
Anatomy, Cross-Sectional
1
2014
10
0.030
 Why?
Extracellular Matrix
1
2019
506
0.030
 Why?
Radiation Dosage
1
2016
154
0.030
 Why?
Flow Cytometry
1
2018
1158
0.030
 Why?
Intraoperative Care
1
2014
46
0.030
 Why?
Kidney Failure, Chronic
3
2004
546
0.030
 Why?
Systemic Inflammatory Response Syndrome
1
2014
85
0.030
 Why?
Immunologic Memory
1
2016
349
0.030
 Why?
Feasibility Studies
1
2017
869
0.030
 Why?
Biomedical Research
1
2019
639
0.030
 Why?
Dose-Response Relationship, Drug
2
2010
2013
0.030
 Why?
Indole Alkaloids
1
2013
7
0.030
 Why?
Antigens, Neoplasm
1
2016
308
0.030
 Why?
Drug Administration Schedule
2
2005
763
0.030
 Why?
Algorithms
1
2020
1614
0.030
 Why?
Cytokines
2
2016
2018
0.030
 Why?
Drug Interactions
2
2005
397
0.030
 Why?
Peptic Ulcer
1
2013
18
0.030
 Why?
Histocompatibility Testing
2
2004
121
0.030
 Why?
Asymptomatic Diseases
1
2013
84
0.020
 Why?
Global Health
1
2015
328
0.020
 Why?
Safety
2
2004
335
0.020
 Why?
Postoperative Care
1
2013
244
0.020
 Why?
Pandemics
1
2020
1500
0.020
 Why?
Lymphocyte Activation
1
2016
1109
0.020
 Why?
Hypoxia
1
2019
1081
0.020
 Why?
Randomized Controlled Trials as Topic
1
2017
1368
0.020
 Why?
Carcinoma, Renal Cell
1
2013
177
0.020
 Why?
Anti-Bacterial Agents
1
2021
1708
0.020
 Why?
In Situ Hybridization
1
2011
296
0.020
 Why?
Korea
1
2010
10
0.020
 Why?
Cell Growth Processes
1
2010
49
0.020
 Why?
Lung
1
2023
3928
0.020
 Why?
Matrix Metalloproteinase 2
1
2010
56
0.020
 Why?
Microsatellite Repeats
1
2011
163
0.020
 Why?
Odds Ratio
1
2013
1018
0.020
 Why?
Biopsy, Needle
1
2010
187
0.020
 Why?
Matrix Metalloproteinase 9
1
2010
123
0.020
 Why?
Cardiovascular Diseases
1
2001
1997
0.020
 Why?
Thyroid Neoplasms
1
2013
305
0.020
 Why?
Blood Glucose
3
2004
2071
0.020
 Why?
Edetic Acid
1
2009
49
0.020
 Why?
Pyridoxal Phosphate
1
2009
21
0.020
 Why?
Kidney Neoplasms
1
2013
346
0.020
 Why?
PTEN Phosphohydrolase
1
2010
157
0.020
 Why?
Tetrazolium Salts
1
2008
17
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2010
427
0.020
 Why?
Thiazoles
1
2008
118
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2010
527
0.020
 Why?
Surgical Procedures, Operative
1
2010
242
0.020
 Why?
bcl-2-Associated X Protein
1
2007
55
0.020
 Why?
Glyburide
1
2007
32
0.020
 Why?
Recurrence
1
2010
1011
0.020
 Why?
Epigenesis, Genetic
1
2011
617
0.020
 Why?
Microscopy, Electron
1
2007
423
0.020
 Why?
Deoxycytidine Kinase
1
2006
3
0.020
 Why?
Ribonucleoside Diphosphate Reductase
1
2006
5
0.020
 Why?
Mutation
1
2017
3702
0.020
 Why?
Motorcycles
1
2006
6
0.020
 Why?
Choledochostomy
1
2006
11
0.020
 Why?
Budd-Chiari Syndrome
1
2006
5
0.020
 Why?
Tyrosine
1
2007
222
0.020
 Why?
5'-Nucleotidase
1
2006
39
0.020
 Why?
Fluorescein Angiography
1
2006
142
0.020
 Why?
Cytidine Deaminase
1
2006
57
0.020
 Why?
Colorectal Neoplasms
1
2013
744
0.020
 Why?
Phosphorylation
1
2010
1714
0.020
 Why?
Prostatic Neoplasms
1
2013
995
0.020
 Why?
Economics, Pharmaceutical
1
2005
9
0.020
 Why?
Antilymphocyte Serum
1
2005
63
0.020
 Why?
Hemorrhage
1
2010
680
0.010
 Why?
Blood Group Incompatibility
1
2005
11
0.010
 Why?
Methylprednisolone
1
2005
83
0.010
 Why?
Fatal Outcome
1
2006
300
0.010
 Why?
Maximum Tolerated Dose
1
2005
193
0.010
 Why?
Proteomics
1
2011
1053
0.010
 Why?
Isoantibodies
1
2005
57
0.010
 Why?
Accidents, Traffic
1
2006
184
0.010
 Why?
Glycerolphosphate Dehydrogenase
1
2004
6
0.010
 Why?
Fructose-Bisphosphate Aldolase
1
2004
8
0.010
 Why?
Glucokinase
1
2004
14
0.010
 Why?
Intraocular Pressure
1
2006
299
0.010
 Why?
DNA Primers
1
2005
507
0.010
 Why?
Visual Acuity
1
2006
326
0.010
 Why?
Pyruvate Kinase
1
2004
26
0.010
 Why?
Renal Circulation
1
2004
57
0.010
 Why?
Diabetic Neuropathies
1
2005
94
0.010
 Why?
Tissue Culture Techniques
1
2004
75
0.010
 Why?
Transcriptional Activation
1
2006
366
0.010
 Why?
Pharmacogenetics
1
2005
172
0.010
 Why?
Tumor Suppressor Proteins
1
2006
311
0.010
 Why?
Carcinoma, Transitional Cell
1
2003
59
0.010
 Why?
Monitoring, Physiologic
1
2005
261
0.010
 Why?
Kidney Function Tests
1
2003
152
0.010
 Why?
Cell Separation
1
2004
315
0.010
 Why?
Respiratory Insufficiency
1
2006
312
0.010
 Why?
In Vitro Techniques
1
2004
1091
0.010
 Why?
Thrombosis
1
2005
348
0.010
 Why?
Base Sequence
1
2005
2138
0.010
 Why?
Obesity, Morbid
1
2005
242
0.010
 Why?
Vulvar Diseases
1
2001
9
0.010
 Why?
Immunoenzyme Techniques
1
2001
211
0.010
 Why?
Gene Expression
1
2006
1461
0.010
 Why?
Glucocorticoids
1
2005
583
0.010
 Why?
Ischemia
1
2004
405
0.010
 Why?
Morphogenesis
1
2001
158
0.010
 Why?
Hemodynamics
1
2004
1094
0.010
 Why?
Neoplasm Proteins
1
2001
417
0.010
 Why?
Blood Pressure
1
2005
1735
0.010
 Why?
T-Lymphocytes
1
2005
1935
0.010
 Why?
Hypoglycemic Agents
1
2005
1219
0.010
 Why?
Body Mass Index
1
2004
2269
0.010
 Why?
Infant, Newborn
1
2001
5769
0.010
 Why?
Del Chiaro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (574) concept(s)
_
Co-Authors Expand Description
See all (53) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)